Emblica officinalis stimulates the secretion and action of insulin and inhibits starch digestion and protein glycation in vitro

V Kasabri; Peter Flatt; YHA Abdel-Wahab

doi:10.9734/EJMP/2014/8585

Emblica officinalis stimulates the secretion and action of insulin and inhibits starch digestion and protein glycation in vitro

Research output: Contribution to journal › Article › peer-review

Abstract

Aim: Medicinal, edible and aromatic plants and natural products have been used worldwide for the management of diabetes mellitus. The aim of this study was to investigate the efficacy and mode of action of Emblica officinalis Gaertn. (Phyllanthaceae) used traditionally for treatment of diabetes. Study Design: Using multiple In vitro models; this study was designed to investigate the antidiabetes efficacy and mode of action of E. officinalis.Place and Duration of Study: School of Biomedical Sciences, University of Ulster, 2001-2004Results: E. officinalis aqueous extracts (AEs) stimulated basal insulin output and potentiated glucose-stimulated insulin secretion concentration-dependently in the clonal pancreatic beta cell line, BRIN-BD11 (p

Original language	English
Pages (from-to)	753-770
Journal	European Journal of Medicinal Plants
Volume	4
Issue number	6
DOIs	https://doi.org/10.9734/EJMP/2014/8585
Publication status	Published (in print/issue) - 20 Mar 2014

Keywords

Emblica officinalis Gaertn
(Phyllanthaceae)
insulin secretion
insulin action
starch digestion
peptide glycation.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.9734/EJMP/2014/8585

Cite this

@article{0ad97c4f70a54a98814eb0858558f697,

title = "Emblica officinalis stimulates the secretion and action of insulin and inhibits starch digestion and protein glycation in vitro",

abstract = "Aim: Medicinal, edible and aromatic plants and natural products have been used worldwide for the management of diabetes mellitus. The aim of this study was to investigate the efficacy and mode of action of Emblica officinalis Gaertn. (Phyllanthaceae) used traditionally for treatment of diabetes. Study Design: Using multiple In vitro models; this study was designed to investigate the antidiabetes efficacy and mode of action of E. officinalis.Place and Duration of Study: School of Biomedical Sciences, University of Ulster, 2001-2004Results: E. officinalis aqueous extracts (AEs) stimulated basal insulin output and potentiated glucose-stimulated insulin secretion concentration-dependently in the clonal pancreatic beta cell line, BRIN-BD11 (p",

keywords = "Emblica officinalis Gaertn, (Phyllanthaceae), insulin secretion, insulin action, starch digestion, peptide glycation.",

author = "V Kasabri and Peter Flatt and YHA Abdel-Wahab",

year = "2014",

month = mar,

day = "20",

doi = "10.9734/EJMP/2014/8585",

language = "English",

volume = "4",

pages = "753--770",

journal = "European Journal of Medicinal Plants",

issn = "2231-0894",

publisher = "SCIENCEDOMAIN International",

number = "6",

}

TY - JOUR

T1 - Emblica officinalis stimulates the secretion and action of insulin and inhibits starch digestion and protein glycation in vitro

AU - Kasabri, V

AU - Flatt, Peter

AU - Abdel-Wahab, YHA

PY - 2014/3/20

Y1 - 2014/3/20

N2 - Aim: Medicinal, edible and aromatic plants and natural products have been used worldwide for the management of diabetes mellitus. The aim of this study was to investigate the efficacy and mode of action of Emblica officinalis Gaertn. (Phyllanthaceae) used traditionally for treatment of diabetes. Study Design: Using multiple In vitro models; this study was designed to investigate the antidiabetes efficacy and mode of action of E. officinalis.Place and Duration of Study: School of Biomedical Sciences, University of Ulster, 2001-2004Results: E. officinalis aqueous extracts (AEs) stimulated basal insulin output and potentiated glucose-stimulated insulin secretion concentration-dependently in the clonal pancreatic beta cell line, BRIN-BD11 (p

AB - Aim: Medicinal, edible and aromatic plants and natural products have been used worldwide for the management of diabetes mellitus. The aim of this study was to investigate the efficacy and mode of action of Emblica officinalis Gaertn. (Phyllanthaceae) used traditionally for treatment of diabetes. Study Design: Using multiple In vitro models; this study was designed to investigate the antidiabetes efficacy and mode of action of E. officinalis.Place and Duration of Study: School of Biomedical Sciences, University of Ulster, 2001-2004Results: E. officinalis aqueous extracts (AEs) stimulated basal insulin output and potentiated glucose-stimulated insulin secretion concentration-dependently in the clonal pancreatic beta cell line, BRIN-BD11 (p

KW - Emblica officinalis Gaertn

KW - (Phyllanthaceae)

KW - insulin secretion

KW - insulin action

KW - starch digestion

KW - peptide glycation.

U2 - 10.9734/EJMP/2014/8585

DO - 10.9734/EJMP/2014/8585

M3 - Article

SN - 2231-0894

VL - 4

SP - 753

EP - 770

JO - European Journal of Medicinal Plants

JF - European Journal of Medicinal Plants

IS - 6

ER -

Emblica officinalis stimulates the secretion and action of insulin and inhibits starch digestion and protein glycation in vitro

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this